Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ IGFBP-1 Monoclonal Antibody (D9)
Mouse Monoclonal Antibody
Supplier: Invitrogen™ MA543695
Description
IGFBP-1 Monoclonal Antibody for Western Blot, ICC/IF, IHC (P)
This gene is a member of the insulin-like growth factor binding protein (IGFBP) family and encodes a protein with an IGFBP domain and a thyroglobulin type-I domain. The protein binds both insulin-like growth factors (IGFs) I and II and circulates in the plasma. Binding of this protein prolongs the half-life of the IGFs and alters their interaction with cell surface receptors.
Specifications
IGFBP-1 | |
Monoclonal | |
1 mg/mL | |
PBS with 50% glycerol and 0.05% ProClin 300 | |
P08833 | |
IGFBP1 | |
Recombinant protein Insulin Like Growth Factor Binding Protein 1. The antigen corresponds to amino acid range 36-235 of the target protein. | |
20 μL | |
Primary | |
Human | |
Antibody | |
IgG1 κ |
Immunohistochemistry (Paraffin), Western Blot, Immunocytochemistry | |
D9 | |
Unconjugated | |
IGFBP1 | |
AFBP; alpha-pregnancy-associated endometrial globulin; amniotic fluid binding protein; Binding protein 25; Binding protein 26; Binding protein 28; binding protein-25; binding protein-26; binding protein-28; growth hormone independent-binding protein; hIGFBP 1; hIGFBP1; hIGFBP-1; IBP 1; IBP1; IBP-1; IGF BP25; IGFBA; IGF-binding protein 1; IGFBP; IGFBP 1; Igfbp1; Igfbp-1; IGF-BP25; Insulin like growth factor binding protein; insulin like growth factor binding protein 1; insulin-like growth factor binding protein 1; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1 PRECURSOR (IGFBP-1) (IBP-1) (IGF-BINDING PROTEIN 1); insulin-like growth factor-binding protein 1; Placental protein 12; PP 12; PP12 | |
Mouse | |
Protein A/G | |
RUO | |
3484 | |
-20°C | |
Liquid |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction